0001883850-22-000046.txt : 20220518
0001883850-22-000046.hdr.sgml : 20220518
20220518160501
ACCESSION NUMBER: 0001883850-22-000046
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220516
FILED AS OF DATE: 20220518
DATE AS OF CHANGE: 20220518
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MURPHY ANDREW J
CENTRAL INDEX KEY: 0001796226
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 22939066
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2022-05-16
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001796226
MURPHY ANDREW J
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
EVP Research
Common Stock
2022-05-16
4
M
0
10000
179.13
A
68470
D
Common Stock
2022-05-16
4
F
0
6457
648.31
D
62013
D
Common Stock
2022-05-17
4
S
0
59
655.4
D
61954
D
Common Stock
2022-05-17
4
S
0
58
656.52
D
61896
D
Common Stock
2022-05-17
4
S
0
60
657.51
D
61836
D
Common Stock
2022-05-17
4
S
0
123
658.56
D
61713
D
Common Stock
2022-05-17
4
S
0
77
660.32
D
61636
D
Common Stock
2022-05-17
4
S
0
465
661.46
D
61171
D
Common Stock
2022-05-17
4
S
0
779
662.57
D
60392
D
Common Stock
2022-05-17
4
S
0
472
663.6
D
59920
D
Common Stock
2022-05-17
4
S
0
428
664.32
D
59492
D
Common Stock
2022-05-17
4
S
0
126
665.36
D
59366
D
Common Stock
2022-05-17
4
S
0
352
666.23
D
59014
D
Common Stock
2022-05-17
4
S
0
154
667.49
D
58860
D
Common Stock
2022-05-17
4
S
0
180
668.68
D
58680
D
Common Stock
2022-05-17
4
S
0
153
669.12
D
58527
D
Common Stock
2022-05-17
4
S
0
57
670.49
D
58470
D
Common Stock
4285
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
179.13
2022-05-16
4
M
0
10000
0.0
D
2022-12-14
Common Stock
10000
20000
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 77 shares of Company stock on May 17, 2022 at prices ranging from $660.18 to $660.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.
Represents volume-weighted average price of sales of 465 shares of Company stock on May 17, 2022 at prices ranging from $661.16 to $661.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.
Represents volume-weighted average price of sales of 779 shares of Company stock on May 17, 2022 at prices ranging from $662.29 to $662.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.
Represents volume-weighted average price of sales of 472 shares of Company stock on May 17, 2022 at prices ranging from $663.20 to $663.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.
Represents volume-weighted average price of sales of 428 shares of Company stock on May 17, 2022 at prices ranging from $664.01 to $664.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.
Represents volume-weighted average price of sales of 352 shares of Company stock on May 17, 2022 at prices ranging from $666.11 to $666.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.
Represents volume-weighted average price of sales of 154 shares of Company stock on May 17, 2022 at prices ranging from $667.27 to $667.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.
Represents volume-weighted average price of sales of 180 shares of Company stock on May 17, 2022 at prices ranging from $668.41 to $668.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.
Represents volume-weighted average price of sales of 153 shares of Company stock on May 17, 2022 at prices ranging from $669.00 to $669.21. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.
The stock option award vests in four equal annual installments, commencing one year after the date of grant.
/s/**Andrew Murphy
2022-05-17